Publications

Selected Recent Publications

• Deletion of arrestin-3 does not alter compulsive morphine-seeking behavior in an oral operant self-administration paradigm (2023)

• Arrestin-3 agonism at D3 dopamine receptors defines a subclass of second generation antipsychotics that promotes drug tolerance (2023)

• Pharmacological and genetic manipulations at the µ-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice (2021)

• Identification of the first marine-derived opioid receptor “balanced” agonist with a signaling profile that resembles the endorphins (2017)

• β-arrestin-dependent dopaminergic regulation of calcium channel activity in the axon initial segment (2016)

• Identification of the kappa-opioid receptor as a therapeutic target for oligodendrocyte remyelination (2016)

• Real-time trafficking and signaling of the glucagon-like peptide-1 receptor (2014)

• Trafficking of the D2 Dopamine Receptor Promotes Drug-Induced Changes in Neuronal and Behavioral Plasticity (2014)

• Beclin 2 functions in autophagy, degradation of G protein-coupled receptors, and metabolism (2013)

• Loss of D2 dopamine receptor function modulates cocaine-induced glutamatergic synaptic potentiation in the ventral tegmental area (2013)

• Anti-Analgesic Effect of the Mu/Delta Opioid Receptor Heteromer Revealed by Ligand-Biased Antagonism (2013)